The WHO recommends trials of the Ervebo vaccine to try to curb the current outbreak in the DRC

On Friday, August 7, in Geneva, the World Health Organization (OMS) announced that its advisors have recommended prioritizing the Ervebo vaccine for human clinical trials. The measure is intended to help respond to the ongoing outbreak of the Ebola virus in the Democratic Republic of the Congo.

The recommendation by the WHO advisory group marks a strategic step in utilizing clinical trials to evaluate and deploy the vaccine against the current epidemic affecting the region.